Obermatt
See Similar Stocks →

Becton Dickinson

NYQ:BDX · US0758871091
Health Care Equipment & SuppliesXX-Large

360

32
EV / EBIT89
Price / Owner Earnings81
Owner Earnings Yield87
Dividend Yield99
Price/Sales64
EV / Gross Profit49
Price/Book65
Return on Capital27
Cash Return on Capital41
Return on Equity23
EBIT Margin48
Gross Profitability12
Cash Conversion96
Accruals79
Owner Earnings Margin61
Sales growth4
Profit Growth91
Long-Term EPS Growth20
Owner Earnings Growth33
Reinvestment27
Price momentum76
Debt load36
Refinancing39
Debt Payback14
Liquidity70
Analyst ratings16
Opinion Changes81
Price Target Upside52
Market mood59
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Becton Dickinson clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeXX-Large
TypePublic Company
ExchangeNYSE
Founded1906
Employees32,315
Websitebd.com
ISINUS0758871091
Last UpdateApr 2, 2026
Indices
S&P 500 (USA)D.J. US Health CareD.J. US Medical Equipment
Themes
HematologyUrologyHealth DiagnosticsImmunologyBiomedical EngineeringIndustrial AutomationInfectious DiseasesSurgeryDetectors, Sensors and MemsOncologyHealth CareMedical DeviceTechnical Support

Description

Becton, Dickinson and Company (BD) operate as a global medical technology company. The company engages in the development, manufacture, and sale of a broad range of medical supplies, devices, laboratory equipment, and diagnostic products used by heal…

Analysis

Bargain bin

Becton, Dickinson and Company falls in the bargain bin: the price is low relative to peers, but the business metrics give reason to pause.

The price is attractive. You pay 14.3× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly 2% yearly growth; analysts expect 3%. The price, in other words, assumes less than the experts do.

The trajectory is tepid and the balance sheet is stretched. The company scores 12/20 on our value-creation score: creating some value.

What to watch: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
72
2023202420252026

All-time high

92

Jan 2023

All-time low

23

Mar 2026

Average rank

67

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
64
46
49
57
Price/Earnings
43
69
69
78
Price/Book
65
57
68
89
Dividend Yield
99
100
93
94
Value (overall)
98
92
93
98

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Becton Dickinson with its peers
Teleflex
NYQ:TFX
5
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
AngioDynamics
NSQ:ANGO
57
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Integer
NYQ:ITGR
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
GE Healthcare
NSQ:GEHC
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Boston Scientific
NYQ:BSX
75
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Ascendis Pharma
NSQ:ASND
45
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →